EP3962459A4 - Pharmaceutical compositions comprising tolperisone and nimesulide combinations - Google Patents

Pharmaceutical compositions comprising tolperisone and nimesulide combinations Download PDF

Info

Publication number
EP3962459A4
EP3962459A4 EP20798008.7A EP20798008A EP3962459A4 EP 3962459 A4 EP3962459 A4 EP 3962459A4 EP 20798008 A EP20798008 A EP 20798008A EP 3962459 A4 EP3962459 A4 EP 3962459A4
Authority
EP
European Patent Office
Prior art keywords
tolperisone
nimesulide
combinations
pharmaceutical compositions
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP20798008.7A
Other languages
German (de)
French (fr)
Other versions
EP3962459A1 (en
Inventor
Seyhan TURKKAN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanovel Ilac Sanayi ve Ticaret AS
Original Assignee
Sanovel Ilac Sanayi ve Ticaret AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi ve Ticaret AS filed Critical Sanovel Ilac Sanayi ve Ticaret AS
Publication of EP3962459A1 publication Critical patent/EP3962459A1/en
Publication of EP3962459A4 publication Critical patent/EP3962459A4/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
EP20798008.7A 2019-04-30 2020-03-23 Pharmaceutical compositions comprising tolperisone and nimesulide combinations Pending EP3962459A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2019/06487A TR201906487A1 (en) 2019-04-30 2019-04-30 PHARMACEUTICAL COMPOSITIONS CONTAINING TOLPERISONE AND NIMESULIDE COMBINATIONS
PCT/TR2020/050229 WO2020222714A1 (en) 2019-04-30 2020-03-23 Pharmaceutical compositions comprising tolperisone and nimesulide combinations

Publications (2)

Publication Number Publication Date
EP3962459A1 EP3962459A1 (en) 2022-03-09
EP3962459A4 true EP3962459A4 (en) 2023-01-25

Family

ID=73028767

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20798008.7A Pending EP3962459A4 (en) 2019-04-30 2020-03-23 Pharmaceutical compositions comprising tolperisone and nimesulide combinations

Country Status (3)

Country Link
EP (1) EP3962459A4 (en)
TR (1) TR201906487A1 (en)
WO (1) WO2020222714A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1362585A2 (en) * 2001-01-26 2003-11-19 Osmotica Corp. Pharmaceutical compositions containing a cox-ii inhibitor and a muscle relaxant
WO2010103544A2 (en) * 2009-03-09 2010-09-16 Dinesh Shantilal Patel A novel sustained release composition of compounds selected from the class of centrally acting muscle relaxants
WO2010128525A2 (en) * 2009-05-04 2010-11-11 Dinesh Shantilal Patel A formulation of ivabradine for treating the cardiovascular disease
WO2014125085A1 (en) * 2013-02-15 2014-08-21 Sanovel Ilac Sanayi Ve Ticaret A.S. Oral pharmaceutical formulations comprising nimesulide and thiocolchicoside
WO2019203751A2 (en) * 2017-12-13 2019-10-24 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Tolperisone and selective cox-2 inhibitor combinations

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN190963B (en) * 2000-06-20 2003-09-06 Ajanta Pharma Ltd

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1362585A2 (en) * 2001-01-26 2003-11-19 Osmotica Corp. Pharmaceutical compositions containing a cox-ii inhibitor and a muscle relaxant
WO2010103544A2 (en) * 2009-03-09 2010-09-16 Dinesh Shantilal Patel A novel sustained release composition of compounds selected from the class of centrally acting muscle relaxants
WO2010128525A2 (en) * 2009-05-04 2010-11-11 Dinesh Shantilal Patel A formulation of ivabradine for treating the cardiovascular disease
WO2014125085A1 (en) * 2013-02-15 2014-08-21 Sanovel Ilac Sanayi Ve Ticaret A.S. Oral pharmaceutical formulations comprising nimesulide and thiocolchicoside
WO2019203751A2 (en) * 2017-12-13 2019-10-24 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Tolperisone and selective cox-2 inhibitor combinations

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2020222714A1 *

Also Published As

Publication number Publication date
TR201906487A1 (en) 2020-11-23
WO2020222714A1 (en) 2020-11-05
EP3962459A1 (en) 2022-03-09

Similar Documents

Publication Publication Date Title
EP3917497A4 (en) Oligonucleotide compositions and methods thereof
EP3891284A4 (en) Oligonucleotide compositions and methods thereof
EP3706741A4 (en) Pharmaceutical composition and use thereof
EP3946315A4 (en) Cannabinoid compositions and use thereof
EP4023227A4 (en) Pharmaceutical composition and application thereof
EP3897593A4 (en) Cannabinoid formulations and pharmaceutical compositions
EP3773654A4 (en) Polypharmaceutical drug compositions and related methods
EP3917910A4 (en) Therapeutic compounds and compositions
EP3873444A4 (en) Therapeutic compounds and compositions
EP4063489A4 (en) Composition and use thereof
EP4082579A4 (en) Polynucleotide and medicinal composition
EP4082614A4 (en) Acylsulfamide compound and pharmaceutical use therefor
EP4019521A4 (en) Azaheteroaryl compound and application thereof
EP3873446A4 (en) Therapeutic compounds and compositions
EP3777866A4 (en) Pharmaceutical composition and application thereof
EP3999056A4 (en) Pharmaceutical combination and use thereof
EP3817744A4 (en) Ivosidenib forms and pharmaceutical compositions
EP3950677A4 (en) Quinolyl-containing compound and pharmaceutical composition, and use thereof
EP3805210A4 (en) Novel compound and pharmaceutical composition comprising same
EP3749662A4 (en) Therapeutic compounds and compositions
ZA202104261B (en) Combination pharmaceutical compositions and methods thereof
EP4015516A4 (en) Benzofuran-based n-acylhydrazone derivative and pharmaceutical composition comprising same
EP3962459A4 (en) Pharmaceutical compositions comprising tolperisone and nimesulide combinations
EP4032535A4 (en) Pharmaceutical composition
EP4069233A4 (en) Pharmaceutical combination and use thereof

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20211028

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20230102

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/24 20060101ALI20221220BHEP

Ipc: A61K 47/14 20170101ALI20221220BHEP

Ipc: A61K 47/12 20060101ALI20221220BHEP

Ipc: A61K 47/02 20060101ALI20221220BHEP

Ipc: A61P 21/02 20060101ALI20221220BHEP

Ipc: A61P 29/00 20060101ALI20221220BHEP

Ipc: A61K 31/63 20060101ALI20221220BHEP

Ipc: A61K 31/18 20060101ALI20221220BHEP

Ipc: A61K 31/4453 20060101ALI20221220BHEP

Ipc: A61K 9/20 20060101AFI20221220BHEP

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230708

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20231213